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ABSTRACT 
Background: Ascorbic acid has been suggested to be effective against chemical burns. It was first tested in rabbits before being 
implemented in human subjects. It was proven to be useful in treatments for different conditions, such as corneal chemical and 
thermal burns. Herein, we aimed to review the effects of ascorbic acid in the healing of chemical and thermal corneal burns. 
Methods: We performed an electronic search of English literature in MEDLINE, clinicaltrials.gov, and Google Scholar, without 
time constraints. Articles were selected based on inclusion and exclusion criteria, using they keywords “Corneal Burn,” AND 
“Corneal Ulcer,” AND “Vitamin C.” This yielded 17 English language articles focused on the effect of vitamin C on chemical or 
thermal corneal burn-induced ulcers.  
Results: The 17 eligible studies that fulfilled the inclusion criteria included three retrospective, nonrandomized, comparative 
studies on human subjects and 14 in vivo, laboratory-based studies on rabbits (12 studies), rats (one study), as well as guinea-
pigs (one study). Most studies showed benefits in using vitamin C as a prophylactic treatment to delay or stop corneal ulcer 
formation after chemical or thermal corneal burn. 
Conclusions: Vitamin C is a very basic, inexpensive prescription and can be used to treat corneal ulcers following a variety of 
corneal burns. This review highlights the necessity for conducting randomized controlled trials to investigate the prophylactic role 
of vitamin C and to determine its minimum required dose for the management of corneal ulcers after different types of corneal 
burns. 
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INTRODUCTION 
 
Vitamin C or ascorbic acid has been shown to offer 
protection against immune system defects [1-3], 
cardiovascular disease [4, 5], maternal health problems, 
eye disease, and skin wrinkling [6-8] are among the 
advantages of vitamin C. Vitamin C has been 
demonstrated to have potent antioxidant [4], antitumor, 
[2] and antiviral activities [9-11]. Since 1946, as the first 
research on this topic, ascorbic acid has been proposed to 
be an effective modality for treating corneal chemical 
burns [12-17]. Initially, the effects of vitamin C were 
examined in rabbits, and the findings were later 
implemented in human subjects. The results showed 
promising effects in the treatment of corneal chemical 
burns [18]. One randomized clinical trial showed that a 
high dose of vitamin C improved the patients’ ventricular 
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A high dose was defined as 5 g of intravenous vitamin C 
and 5 g of vitamin C in a cardioplegic solution [5]. 
According to U.S. Food and Nutrition Board the current 
recommended dietary intake of 45 milligrams (mg) a day 
of vitamin C for adults is expected to be changed to the 
minimum dietary intake [19] as this dose is sufficient to 
prevent scurvy [19]. However, the current recommended 
dietary allowance or RDA for adult, non-smoking men and 
women, is 60 mg/day, and this  exactly addresses a mean 
requirement of 46 mg/day to prevent scurvy deficiency 
[20]. Ascorbic acid was proven to be useful in treatments 
for different conditions, such as corneal chemical and 
thermal burns. This review aimed to assess the role of 
ascorbic acid in the healing of chemical and thermal 
corneal burns and to discuss the optimal dose for 
preventing corneal ulcers as presented in the literature.   
METHODS 
This review included an electronic search of MEDLINE, 
clinicaltrials.gov, and Google Scholar, with language 
limited to English but without time constraints, using the 
keywords ‘Corneal Burn’, AND ‘Corneal Ulcer’, AND 
‘Vitamin C’.” 
RESULTS  
The search yielded 17 eligible studies that fulfilled the 
inclusion criteria. The 17 selected articles included three 
retrospective, nonrandomized, comparative studies on 
human subjects and 14 in vivo, laboratory-based studies. 
The details of these studies are outlined in Table 1. Most 
studies showed benefits of using vitamin C as a 
prophylactic treatment that delays or stops corneal ulcer 
from developing after corneal burns.  
Alkali Burn: Levinson et al. showed that exogenous 
maintenance of sufficient aqueous humor levels of 
ascorbic acid could resolve the comparatively scorbutic 
state of the anterior segment following an alkali burn of 
12 mm in rabbit eyes, thus reducing the development of 
corneal ulceration and perforation [21]. Pfister and 
Paterson reported that their data strongly suggested 
that alkali-burned rabbit cornea is a localized scorbutic 
tissue, because corneal ulceration and perforation may 
develop following a severe drop in the synthesis of 
corneal collagen in the face of denatured collagen 
resorption. Ulceration may be avoided if aqueous humor 
ascorbate is retained at over 15 mg per 100 mL (mg/100 
mL) for 24 h after parenteral administration [22]. Pfister 
et al. showed that two drops of 10% topical ascorbate 
administered hourly for 14 h of the day significantly 
reduced the occurrence of ulcer development after 
experimental alkali burns in rabbit eyes [23]. Pfister 
and Paterson stressed the importance of vitamin C and 
indicated that the development of corneal ulceration 
may be related to fibroblasts failing to produce 
sufficient collagen, which requires vitamin C, to repair 
the lesion [24]. Treatment with vitamin C may be 
administered 24‒48 hours after the burn, with a 
dosage of topical drops 14 times daily to derive 
benefit. Furthermore, simultaneous oral and topical 
routes of medication may yield the greatest benefits 
[38].
Table 1. Summary of the 17 articles on the effect of ascorbic acid on thermal or chemical burn-induced corneal ulcers included in this review. 
N Author & date  Type of Study Type of Burn Route of Administration 
1 Levinson et al., 1976 [21]  Experimental (Rabbit) Alkali Burn Subcutaneous 
2 Pfister and Paterson, 1977 [22]   Experimental (Rabbit) Alkali Burn Parenterally Subcutaneous 
3 Pfister et al., 1978 [23] Experimental (Rabbit) Alkali Burn Topical 
4 Pfister and Paterson, 1980 [24] Experimental (Rabbit) Alkali Burn Parenteral or Topical 
5 Pfister et al., 1981 [25] Experimental (Rabbit) Alkali Burn Topical 
6 Pfister et al., 1982 [26] Experimental (Rat) Alkali Burn Topical 
7 Reim et al., 1982 [27] Experimental (Rabbit) Alkali Burn Subcutaneous 
8 Petroutsos et al., 1984 [28] Experimental (Rabbit) Alkali Burn Topical 
9 Pfister et al., 1988 [29] Experimental (Rabbit) Alkali Burn Topical 
10 Pfister et al., 1991 [30] Experimental (Rabbit) Alkali Burn Topical 
11 Wishard and Paterson, 1980 [31] Experimental (Rabbit) Alkali and Acidic Burn Subcutaneous 
12 Campbell and Ferguson, 1950 [32] Experimental (Guinea-pigs) Thermal Burn Orally 
13 Pfister et al., 1981 [33] Experimental (Rabbit) Thermal Burn Parenterally, Subcutaneous 
14 Phan et al., 1985 [34]  Experimental (Rabbit) Thermal Burn Topical and Systemic 
15 Beare, 1990 [35] 64 Patients Chemical Burn Topical 
16 Saini and Sharma, 1993 [36] 102 Patients Chemical Burn Systemic 
17 Brodovosky et al., 2000 [37] 121 Patients Alkali Burn Topical 
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Pfister et al. demonstrated that topical citrate has the 
most beneficial effect on the occurrence of corneal 
ulceration and perforation after alkali burn [25]. 
Pfister et al. also established that 10% topical 
ascorbate does not significantly alter the results of 
existing corneal ulcers in the absence of perforation in 
rats [26]. Reim et al. showed that systemic ascorbate 
therapy did not improve the rate of corneal epithelium 
healing, but improved levels of adenosine 
triphosphate (ATP) and diphosphate (ADP), and the 
ATP/ADP ratio, and reduced glutathione [27]. 
Petroutsos et al. () showed that ascorbic acid therapy 
significantly reduced the incidence of corneal 
ulcerations and perforations in rabbits compared to 
the control group that received sorbitol, buffer, 
parabens, and thimerosal-containing vehicle. These 
results confirmed those of previous studies and 
strongly suggested that a 2% ascorbic acid ophthalmic 
solution has potential for use in human eyes with 
alkali burns [28]. 
Pfister et al. studied corneal alkali injuries that 
resulted in an experimental model of induced 
anterior, middle, or posterior corneal ulcers. They 
showed that both citrate and ascorbate/citrate had a 
positive effect on the depth of the corneal ulcer injury 
due to the reduced number of perforations and 
improved stability in both treatment groups [29].  
Pfister et al. studied whether the combined treatment 
with topical citrate and ascorbate had additional 
therapeutic value compared with citrate alone in 
alkali-injured rabbit eyes. In two groups of animals, 
two drops of 10% citrate were instilled every hour and 
two drops of 10% citrate together with 10% ascorbate 
were instilled every hour for 14 hours per day. They 
reported significantly fewer ulcerations in the 
citrate/ascorbate group during the experiment as 
compared with the group receiving citrate alone [30]. 
Brodovsky et al. showed that grade 1 or grade 2 
human alkali injuries do not benefit from ascorbate 
and citrate treatment. In comparison, grade 3 alkali 
burns recovered easily, and their visual outcome was 
better with ascorbate and citrate treatment, whereas 
grade 4 burns did not show any difference [37]. 
 
Acidic Burn: Our literature search yielded only three 
articles on ocular acidic burns and vitamin C, 
indicating a need for more articles and clinical trials 
concerning this sight-threatening entity. Wishard and 
Paterson showed that subcutaneous injection of 1.5 
grams/10 mL vitamin C per day into extremely acid-
burned corneas in rabbits significantly restored 
ascorbate levels in the aqueous humor, and effectively 
prevented the incidence of corneal ulceration and 
perforation following acid burn. The group also 
postulated that the mechanism was similar to that 
observed in alkali-burned eyes [31]. Beare showed 
that severe chemical eye burns remained poor even 
following administration of ascorbate and steroid 
treatment [35]. 
Saini and Sharma studied the clinical and demographic 
profiles of ocular burns in India [36]. The group 
recommended systemic administration of high-dose 
ascorbic acid (6‒8 g/day) [36]. 
 
Thermal Burn: We also identified only three articles 
on thermal burns and vitamin C [32-34], indicating the 
need for further research and clinical trials in this 
field. Campbell and Ferguson noted that corneal 
neovascularization is caused by ascorbate deficiency. 
Their findings indicated that ascorbic acid deficiency 
increased the occurrence of corneal vascularization 
after injury [32]. Pfister et al. concluded that 
parenteral ascorbate administration had little positive 
effect on tensile strength in corneal wounds in rabbit 
eyes. Subcutaneous ascorbate, on the other hand, had 
a very beneficial effect on corneal wound tensile 
strength in eyes with depressed aqueous humor 
ascorbate levels [33]. Phan et al. showed that, in 
contrast to chemical burn-induced corneal ulcers, in 
rabbits with thermal burn-induced ulceration that 
were treated with both topical and systemic ascorbic 
acid, the incidence of ulceration remained unchanged, 
the occurrence of perforation was enhanced, and 
healing was not accelerated. The onset of ulceration 
following thermal burn was accelerated after systemic 
administration of ascorbic acid [34]. 
DISCUSSION 
The findings of the most aforementioned studies 
demonstrated that vitamin C has a protective effect 
on chemical and thermal burn-induced corneal ulcers, 
yet one suggests its detrimental effects in enhancing 
ulceration following corneal thermal burn. However, 
many of the studies were experimental investigations, 
with only a few human studies. This highlights the 
necessity of conducting randomized clinical trials 
(RCTs) on the use of vitamin C administration as a 
preventive measure for thermal and chemical-induced 
corneal ulcers. The mechanism underlying corneal 
burns involves penetration of cell membranes by 
alkaline substances or acidic substances.               
Alkaline substances can penetrate cell membranes 
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because of their lipophilic properties. They dissociate 
in the ocular surface into hydroxyl ions and cations. 
The hydroxyl ion saponifies cell membrane fatty acids, 
whereas the cation interacts with stromal collagen 
and glycosaminoglycans (GAGs). This interaction 
enables deeper penetration within and through the 
cornea, into the anterior segment. Subsequent 
hydration of the GAGs results in stromal haze. Corneal 
haze mostly appears after trauma, and is caused by 
inflammatory cell activation [39, 40]. On the other 
hand, acidic compounds, which are defined as those 
with pH < 4, create a barrier by binding to tissue 
proteins [41]. 
Corneal haze corresponds to the severity of the 
chemical burns and prognosis, according to the 
modified Hughes classification by Ballen and Roper-
Hall [13]. They defined the severity of the chemical 
burn using four grades. Grade 1 was defined as having 
corneal epithelial damage, with no corneal haze and 
limbal ischemia, together with a good prognosis. 
Grade 2 was defined as some corneal haze but visible 
iris details, limbal ischemia in less than one-third, and 
a good prognosis. Grade 3 has a guarded prognosis 
and is defined as total epithelial loss, stromal haze 
obscuring iris details, and ischemia between one-third 
and half of the limbus. Grade 4 has a poor prognosis 
and manifests as an opaque cornea, invisible iris or 
pupil details, and ischemia affecting more than half of 
the limus [42].  
When corneal injury extends through the stroma, the 
number of keratocytes increases, and some are 
stimulated to become myofibroblasts (Figure 1). 
Keratocytes are specialized fibroblasts that help 
maintain stromal integrity. Keratocytes produce 
collagen, GAGs, and matrix metalloproteinases (MMPs). 
Therefore, precise organization of collagen fibrils within 
the corneal stroma is essential for the maintenance of 
corneal clarity and proper stromal hydration. Keratocyte 
apoptosis is the first stromal event following epithelial 
injury. Soluble epithelium mediators cause cell death via 
apoptosis of stromal keratocytes, while other 
keratocytes are transformed into fibroblasts and 
myofibroblasts. Keratocytes also increase the production 
of chemokines that attract other inflammatory cells from 
the limbal blood supply and tear film to the stroma. 
Corneal stromal myofibroblasts are thought to be 
derived from keratocytes through the influence of 
transforming growth factor (TGB-β) and platelet-derived 
growth factor (PDGF). Corneal stromal myofibroblasts 
create a temporary extracellular matrix (ECM), which is 
essential for collagen and ECM remodeling, as well as for 
the formation and regression of corneal haze (Figure 1) 
[43]. Due to injury, dystrophy, or elevated levels of 
MMP-2 and MMP-9, there is a delay in the regeneration 
of the epithelial basement membrane (EBM) that 
enables TGF-β and PDGF to continue entering the 
corneal stroma from the epithelium, which promotes 
myofibroblast generation. The ongoing presence of 
myofibroblasts can result in an extensively disorganized 
ECM that adds to corneal opacity and scarring. Finally, 
myofibroblasts may also prevent the proper restoration 
of the anterior stromal keratocyte population, which is 
essential for full recovery of EBM. EBM restoration 
requires stabilization of stromal levels of TGF-β and 
PDGF, disappearance of myofibroblasts, repopulation of 
keratocytes, clearing of abnormal ECMs, and restoration 
of corneal clarity (Figure 1) [44].  
Collagen hydration triggers fibril distortion and 
shortening, resulting in trabecular meshwork changes 
that, in effect, cause increased intraocular pressure 
(IOP), which can be long-lasting. Furthermore, the 
inflammatory mediators produced through this cycle 
induce the release of prostaglandins, which can also 
enhance IOP [39, 40, 45]  It has been reported that the 
acid-burn mechanism is similar to in alkali-burned eyes 
[31]. The mechanism underlying corneal perforation 
due to deficiency of ascorbic acid is thought to involve 
the following mechanisms. Pfister et al. (1978) defined 
it as a lack of collagen production due to failure of 
fibroblasts to produce collagen for repair [23]. Pfister 
et al. (1980) reported that the collagen synthesis cycle 
decreases when ascorbic acid is deficient in the face of 
continued collagenase activity [24]. 
It has been proposed that there could be a localized area 
around the site of corneal collagen regeneration where 
the level of ascorbic acid falls below the optimal level for 
rapid healing. Increasing the ascorbic acid level with 
massive doses increased the local collagen replacement 
rate [47]. Few drugs support repair and minimize 
ulceration; however, ascorbic acid and collagenase 
inhibitors have been shown to support repair and 
minimize ulceration [48]. Ascorbate is an essential water-
soluble vitamin that is a cofactor of collagen formation in 
the rate-limiting step. The production of collagen fibrils by 
fibroblasts consists of six steps, as illustrated in Figure 2. 
Procollagen chains are synthesized in the endoplasmic 
reticulum (ER) and are combined by interactions between 
the C-propeptides and fold to form a rod-like triple-helical 
domain flanked by globular N- and C-propeptides. Post-
translational modifications in the ER include removal of 
the N- and C-propeptides from fully folded procollagen 
immediately after transport of procollagen across the 
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Golgi stacks, producing collagen molecules that can be 
assembled into fibrils. Covalent crosslinks occur in fibrils 
within and between triple-helical collagen molecules. The 
fibrils are indeterminate in length, insoluble, and form 
elaborate three-dimensional arrays that transverse 
numerous cell lengths [46]. Ascorbic acid is required 
during ribosomal collagen synthesis as a cofactor for 
proline hydroxylation [24]. Ascorbate supplementation by 
restoring depleted aqueous ascorbate levels decreases 
the incidence of corneal thinning and ulceration. Oral 
ascorbate (2 g/day) and topical 10% solutions formulated 
in artificial tears were effective [48]. Collagenase 
inhibitors that inhibit collagenolytic activity promote 
wound healing, thus preventing ulceration of the 
epithelial tissue. Several collagenase inhibitors have been 
reported to be effective, including cysteine, 
acetylcysteine, and citrate. The only commercially 
available collagenase inhibitor is 10‒20% acetylcysteine 
(Mucomist) [48]. 
Singh et al. emphasized that improvements in 
understanding the pathophysiology of chemical ocular 
injury, such as the use of topical ascorbate and citrate, 
have contributed to better treatment [48]. 
 
 
Figure 1. Corneal wound healing cascade. The process of corneal wound healing is initiated following epithelial injury (1), with subsequent apoptosis and necrosis 
of keratocytes, followed by primary epithelial healing (2). The proliferation and migration of keratocytes, the differentiation and migration of myofibroblasts, and 
the infiltration of inflammatory cells are the next stages of the wound healing cascade (2). Eventually, stromal remodeling and epithelial surface closure occur, 
followed by myofibroblast and inflammatory cell apoptosis and necrosis (3), and return of keratocytes to their normal state (4). Corneal stromal opacity cascade: 
Keratocytes, though the influence of transforming growth factor-beta (TGF-β) and platelet-derived growth factor (PDFG) form myofibroblasts, which lay down a 
provisional extracellular matrix (ECM). The epithelial basement membrane (EBM) degenerates due to matrix metalloproteinase-2 (MMP-2) and MMP-9, allowing 
TGF-β and PDFG to continue entering the corneal stroma from the epithelium (2), which promotes myofibroblasts generation (2,3). The ongoing presence of 
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Figure 2. Summary of the steps involved in the production of collagen fibrils by fibroblasts (1): Chains synthesized in the rough endoplasmic reticulum (RER). (2): 
Interactions between C-propeptides and folding to form a rod-like helical domain, flanked by globular N- and C-propeptides in the RER. (3): Transport of procollagen 
across the Golgi stacks. (4): Procollagen trimer (removal of N- and C- propeptides by N-proteinase and C-proteinase) in the extracellular space. (5): Collagen molecule 
formation. (6): Collagen molecules assemble into fibrils by covalent crosslinks that occur within and between triple-helical collagen molecules [46]. 
On the other hand, Brodovsky et al. performed a 
retrospective, nonrandomized comparative study of 121 
patient records with alkali burns over an 11-year period. This 
study evaluated the clinical outcomes of eyes treated with 
the traditional alkali burn care regimen, which included 
intensive topical steroids, ascorbate, citrate, and antibiotics, 
compared to eyes treated conservatively with antibiotics and 
a short course of steroids. Depending on their results, 
patients with grade 1 or grade 2 injuries did not benefit from 
intensive treatment with ascorbate and citrate. A tendency 
for faster healing and a better final visual outcome was clear 
in grade 3 burns, but their standard protocol did not make 
any difference in grade 4 burns [37]. The main limitation of 
this study was that we included only articles written in the 
English language. The strength of this review integrates 
the information in this subject and highlighted that most 
of the experiments were old and there was little new 
evidence available on this sight-threatening topic. We 
propose that further RCTs should be conducted on the use 
of vitamin C for chemical or thermal ocular burns, to shed 
light on the management of this sight-threatening entity 
and to determine the optimal route of administration and 
dosage of vitamin C. 
CONCLUSIONS 
Vitamin C is a basic, inexpensive prescription that can be 
used to treat corneal ulcers that are induced by various 
types of corneal burns. Further randomized controlled 
trials and prospective studies are required to support the 
prophylactic and therapeutic effects of vitamin C in 
corneal ulcers and corneal burns and to determine the 
optimum dose of vitamin C. However, little is known about 
the effects of ascorbic acid on corneal ulcer development 
after either thermal or alkali burns. This gap in knowledge 
needs to be filled by laboratory experiments and/or 
clinical trials. Finally, vitamin C should not be used as an 
independent mode of treatment, but it could be an 
adjunctive treatment in the management of thermal or 
chemical-induced corneal ulcers.  
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